View, download and print information and resources.
Write your representatives in Congress and urge them to support research for pediatric cancer.
There are many ways you can donate to NCCS. Over 80% of proceeds goes to research.
Exchange information and support with others using Facebook
Medical Research Funded & Supported by NCCS
Following is a list of medical research grants in neuroblastoma children's cancer that have been funded and supported by the Neuroblastoma Children's Cancer Society.
| 2010 | $50,000 | Neuroblastoma Research Grant awarded to Dr. Susan Cohn at the University of Chicago Comer Children's Hospital
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors Epigenetic arnticeletic alterations differ in phenotypically distinct human neuroblastoma cell lines |
| 2009 | $50,000 | Neuroblastoma Research Grant awarded to Dr. Susan Cohn at the University of Chicago Comer Children's Hospital
Presence of cancer-associated fibroblasts inversely correlates with Schawnnian stroma in neuroblastoma tumors - Modern Pathology |
| 2009 | $50,000 | Neuroblastoma Research Grant awarded to Dr. Wendy London (Children's Hospital, Philadelphia) and to the University of Chicago Comer Children's Hospital
Neuroblastoma Virtual Tumor Bank |
| 2008 | $60,000 | Neuroblastoma Research Grant awarded to Dr. Susan Cohn, at the University of Chicago Comer Children's Hospital
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report - Journal of Clinical Oncology |
| 2008 | $50,000 | Neuroblastoma Research Grant awarded to Dr. Robert Seeger at the Children's Hospital Los Angeles
Neuroblastoma Genomic Signatures Predict Survival of Patients |
| 2008 | HR 1553 Legislation passed
Caroline Price Walker Conquer Childhood Cancer Act |
|
| 2007 | $65,000 | Neuroblastoma Research Grant awarded to Dr. Susan Cohn, at the University of Chicago Comer Children's Hospital |
| 2007 | $50,000 | Neuroblastoma Research Grant awarded to Dr. Katherine Matthay, Leader of the NANT Consortium"
New Approaches to Neuroblastoma Therapy (NANT) Consortium Phase I and II Clinical Trials |
Since 1994, NCCS has awarded and supported over $1.5 million in neuroblastoma research grants.
